ClinicalTrials.gov
ClinicalTrials.gov Menu

Tunneled Pleural Catheter in Partially Entrapped Lung

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00637676
Recruitment Status : Completed
First Posted : March 18, 2008
Last Update Posted : September 23, 2011
Sponsor:
Information provided by (Responsible Party):
Felix JF Herth, Heidelberg University

Brief Summary:
An open randomized, prospective, single center; parallel group trial to compare efficiency and safety of PleurX-Pleural Catheter versus standard surgical treatment in patients with malignant pleural effusion and partial entrapment of the lung.

Condition or disease Intervention/treatment Phase
Malignant Pleural Effusion Procedure: VATS, Talc-Pleurodesis, tunneled pleural drainage Procedure: VATS, Talc-pleurodesis Phase 2

Detailed Description:

Patients with malignant pleural effusions undergo VATS-procedure. In the intraoperative finding of a partially entrapped lung, patients are randomized in 2 groups.

Arm 1: Insufflation of talc and insertion of a (standard) drainage which will be removed 4-7 days after surgery.

Arm 2: Insufflation of talc and insertion of a (standard) drainage which will be removed 4-7 days after surgery. Additionally, a subcutaneous tunneled catheter will be inserted and will remain in situ

Follow up period is 3 Months

Primary objective is the comparison of quality of life between the 2 arms.

Secondary objective is the reliability of the subcutaneous tunnelled catheter in practice as well as function and dysfunction of the drainage system. Clinical parameters (respiratory function measured as FEV1 and vital capacity, recurrent pleural effusion, infection, need for relief of effusion or pleuracentesis) are observed.


Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 50 participants
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Single (Investigator)
Primary Purpose: Treatment
Official Title: Randomized Trial of Tunneled Pleural Catheter Versus Standard Chest Tube in Management of Malignant Pleural Effusion in Patients With Partial Entrapment of the Lung
Study Start Date : July 2008
Actual Primary Completion Date : June 2011
Actual Study Completion Date : September 2011

Arm Intervention/treatment
Active Comparator: 1
Implantation of PleurX-Pleural catheter plus talc pleurodesis
Procedure: VATS, Talc-Pleurodesis, tunneled pleural drainage
poudrage of 4 gr talc into the pleural cavity implantation of tunneled pleural catheter
Other Name: Device: PleurX-Pleural Catheter
Active Comparator: 2
talc pleurodesis, no implantation of PleurX-Pleural catheter
Procedure: VATS, Talc-pleurodesis
poudrage of 4 gr. talc into the pleural cavity no tunneled pleural catheter
Other Name: no PleurX-Pleural Catheter



Primary Outcome Measures :
  1. global quality scale QL2 [ Time Frame: 3 months ]

Secondary Outcome Measures :
  1. clinical parameters (respiratory function measured as FEV1 and vital capacity, recurrent pleural effusion, infection, need for relief of effusion or pleuracentesis) [ Time Frame: 3 months ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • One-sided malignant pleural effusion, first occurrence, or following repeated pleuracentesis
  • History of dyspnea relieved after pleuracentesis
  • Patient is suitable for VATS
  • Surgery is indicated by diagnostic necessity
  • Ability of subject to understand character and individual consequences of clinical trial
  • Written informed consent must be available before enrolment in the trial
  • For women with childbearing potential, adequate contraception.
  • Histological proven pleural carcinosis by immediate sectioning
  • Intraoperative: partial entrapment of the lung

Exclusion Criteria:

  • Prior lobectomy or pneumonectomy on the affected side
  • The patient is not operable for general reasons or Karnofsky performance score < 50
  • Intraoperative suspicion of a pleural empyema
  • Chylothorax
  • Prior attempts at pleurodesis
  • Intended or prior intrapleural chemotherapy or radiotherapy
  • Pregnancy and lactation
  • Participation in other competing clinical trials and observation period of competing trials

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00637676


Locations
Germany
Thoraxklinik, University of Heidelberg
Heidelberg, Germany, 69126
Sponsors and Collaborators
Heidelberg University
Investigators
Principal Investigator: Hans Hoffmann, MD, PhD Thoraxklinik, University of Heidelberg

Publications:
Responsible Party: Felix JF Herth, Head, Heidelberg University
ClinicalTrials.gov Identifier: NCT00637676     History of Changes
Other Study ID Numbers: 2802
First Posted: March 18, 2008    Key Record Dates
Last Update Posted: September 23, 2011
Last Verified: March 2008

Keywords provided by Felix JF Herth, Heidelberg University:
malignant pleural effusion
subcutaneous tunneled drainage
talc pleurodesis

Additional relevant MeSH terms:
Pleural Effusion
Pleural Effusion, Malignant
Pleural Diseases
Respiratory Tract Diseases
Pleural Neoplasms
Respiratory Tract Neoplasms
Thoracic Neoplasms
Neoplasms by Site
Neoplasms